Sandler Capital Management’s Pfizer PFE Stock Holding History

Sandler Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,200	Closed	-$212K	–	117
2023 Q1	$212K	Hold	5,200	–	–	0.02%	99
2022 Q4	$266K	Hold	5,200	–	–	0.03%	83
2022 Q3	$228K	Buy	+5,200	New	+$253K	0.03%	74
2019 Q4	–	Sell	-6,429	Closed	-$219K	–	110
2019 Q3	$219K	Hold	6,429	–	–	0.02%	105
2019 Q2	$264K	Hold	6,429	–	–	0.02%	134
2019 Q1	$259K	Sell	6,429 -4,743	-42%	-$190K	0.02%	115
2018 Q4	$463K	Sell	11,172 -14,651	-57%	-$608K	0.04%	89
2018 Q3	$1.08M	Sell	25,823 -7,905	-23%	-$304K	0.05%	100
2018 Q2	$1.16M	Hold	33,728	–	–	0.1%	85
2018 Q1	$1.14M	Hold	33,728	–	–	0.14%	87
2017 Q4	$1.16M	Hold	33,728	–	–	0.16%	98
2017 Q3	$1.14M	Buy	33,728 +422	+1%	+$13.6K	0.14%	84
2017 Q2	$1.06M	Buy	33,306 +7,483	+29%	+$236K	0.12%	110
2017 Q1	$838K	Buy	25,823 +17,691	+218%	+$558K	0.06%	152
2016 Q4	$251K	Hold	8,132	–	–	0.02%	148
2016 Q3	$261K	Buy	+8,132	New	+$272K	0.03%	104
2016 Q2	–	Sell	-15,494	Closed	-$436K	–	135
2016 Q1	$436K	Sell	15,494 -34,924	-69%	-$998K	0.05%	100
2015 Q4	$1.54M	Buy	+50,418	New	+$1.59M	0.15%	112

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Sandler Capital Management's PFE Position: Q2 2023 in Review

Sandler Capital Management sold out of Pfizer (PFE) in Q2 2023, closing a stake of 5,200 shares — an estimated $212K sold.

Sandler Capital Management first reported a position in PFE in Q4 2015 and held it in 18 quarters. The position peaked at $1.54M in Q4 2015. 3,044 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

Sandler Capital Management reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
Sandler Capital Management sold 5,200 Pfizer shares in Q2 2023, an estimated $212K.
Sandler Capital Management first reported a position in Pfizer in Q4 2015 and held it in 18 quarters.
Sandler Capital Management's Pfizer position peaked at $1.54M in Q4 2015.
3,044 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Sandler Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.